1. Scrip

Changing Of The Guard At Merck KGaA With Garijo Succeeding Oschmann As CEO

Ensures Smooth Leadership Transition

 
• By Kevin Grogan

The appointment of Belén Garijo as CEO of the German major from May next year is a small but significant step on the road to addressing gender inequality at the very top level of management in the world of big pharma.

Oschmann_Garijo
Stefan Oschmann and Belen Garijo • Source: Merck KGaA

Belén Garijo, head of Merck KGaA's healthcare division, will take over from Stefan Oschmann as chief executive of the German group next year, doubling the number of female CEOs in the big pharma top 20 to two, alongside GlaxoSmithKline plc's Emma Walmsley.

Garijo, who has been appointed as the new chair of the executive board as well as CEO, will take over...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Executives On The Move

More from Leadership